About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Chicago | 164 Studies

Clinical Trials Alzheimer's DiseaseChicago

Alzheimer's Disease Clinical Trials in Chicago

Find 164 clinical trials for alzheimer's disease near Chicago, Illinois. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 164 trials

CompletedDHA (Docosahexaenoic Acid), an Omega 3 Fatty Acid, in Slowing the Progression of Alzheimer's DiseaseThe purpose of this study is to determine whether chronic DHA (Docosahexaenoic Acid) supplementation slows the progression of cognitive and functional decline in mild to moderate…NCT00440050·Birmingham, Alabama and 50 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

TerminatedProgress of Mild Alzheimer's Disease in Participants on Solanezumab Versus PlaceboTo test the idea that solanezumab will slow the cognitive decline of Alzheimer's Disease (AD) as compared with placebo in participants with mild AD.NCT01900665·Phoenix, Arizona and 197 others

Active not recruitingA Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)The reason for this study is to see how safe and effective the study drug donanemab is in participants with early Alzheimer's disease.NCT04437511·Gilbert, Arizona and 273 others

CompletedCB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia)This study will evaluate evidence-based treatments for adults with mild Primary Progressive Aphasia (PPA).NCT05697380·Chicago, Illinois

TerminatedStudy of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of 2 fixed doses of EVP-6124 compared to placebo for 26 weeks in subjects with mild to moderate Alzheimer's…NCT01969123·Phoenix, Arizona and 81 others

CompletedPatient-Centered Dementia Care Practice Coaching InterventionThe goal of this clinical trial is to compare staff outcomes in long-term care communities who participate in the intervention versus those who do not.NCT06249204·Chicago, Illinois

WithdrawnMobile Phone App for Depression and Anxiety in Young Men Who Are Attracted to MenThe purpose of this study is to determine whether a mobile phone application ("app") for symptoms of depression and anxiety is practical and acceptable to young men who are…NCT02072252·Chicago, Illinois

CompletedSAGE LEAF 2: An Online Program to Reduce Dementia Caregiver BurdenThe goal of this clinical trial is to learn if the SAGE LEAF (Social Augmentation of self-Guided Electronic delivery of the Life Enhancing Activities for Family caregivers) online…NCT06708182·Chicago, Illinois

TerminatedA Trial to Evaluate the Efficacy and Safety of PQ912 in Patients With Early ADThis is a Phase 2A multi-center, randomized, double blind, placebo-controlled, parallel group study of varoglutamstat, with a stage gate to Phase 2B.NCT03919162·Phoenix, Arizona and 21 others

WithdrawnImplementation of AIP Services for Older Adults With ADThis study will longitudinally follow a cohort of older adults to better understand how decisions about aging in place or transitioning to long-term care-and the implementation of…NCT07361601·Chicago, Illinois

CompletedBapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier)This is a multicenter, double-blind, placebo controlled, randomized, outpatient multiple dose study in male and female patients ages 50 to less than 89 years with mild to moderate…NCT00574132·Birmingham, Alabama and 250 others

TerminatedStudy of LY2886721 in Mild Cognitive Impairment Due to Alzheimer's Disease or Mild Alzheimer's DiseaseThe purpose of this Phase 1/Phase 2 study is to evaluate how the body handles the drug and the drug's effect on the body of participants with mild cognitive impairment (MCI) due…NCT01561430·Phoenix, Arizona and 33 others

CompletedImproving Mood and Behavior in Assisted Living Residents Through Skills Training for Their CaregiversThis study will develop a treatment program to reduce mood and behavior problems in assisted living residents who have dementia.NCT00255866·Little Rock, Arkansas and 1 other

CompletedA Multicenter Trial of Rofecoxib and Naproxen in Alzheimer's Disease (NSAID Study)The primary specific aim of this clinical trial is to determine whether treatment with rofecoxib or naproxen for one year will slow the rate of decline of cognitive function in…NCT00004845·Phoenix, Arizona and 39 others

CompletedMemory Impairment Study (Mild Cognitive Impairment Study)The National Institute on Aging (NIA) is launching a nationwide treatment study targeting individuals with mild cognitive impairment (MCI), a condition characterized by a memory…NCT00000173·Phoenix, Arizona and 71 others

UnknownVitamin E in Aging Persons With Down SyndromeThe goal of this study is to determine the safety and efficacy of the administration of vitamin E, which has been shown to delay the progression of Alzheimer's disease, in slowing…NCT00056329·Farmington, Connecticut and 21 others

CompletedLong-term Safety of Tafamidis in Subjects With Transthyretin CardiomyopathyOpen label study to evaluate tafamidis for the treatment of transthyretin cardiomyopathyNCT02791230·Birmingham, Alabama and 79 others

TerminatedStudy to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's TypeThis study was conducted to evaluate the efficacy, safety, and tolerability of AVP-786 (deudextromethorphan hydrobromide \[d6-DM\]/quinidine sulfate \[Q\]) compared to placebo for…NCT04464564·Phoenix, Arizona and 105 others

Active not recruitingA Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's DiseaseThis is a multicenter randomized, double-blind, placebo-controlled Phase 2 study designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to…NCT05531656·Birmingham, Alabama and 49 others

CompletedAAB-001 in Patients With Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to assess the safety and tolerability of multiple doses of AAB-001 passive immunization in patients with mild to moderate Alzheimer's disease (AD).NCT00112073·Sun City, Arizona and 25 others

Page 1 of 9Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia